Increasing antimalarial drug resistance in Uganda and revision of the national drug policy
- 11 December 2002
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 7 (12) , 1031-1041
- https://doi.org/10.1046/j.1365-3156.2002.00974.x
Abstract
Chloroquine (CQ) resistance was first documented in Uganda in 1988. Subsequent surveillance of antimalarial drug resistance, conducted by the Ugandan Ministry of Health and several research organizat...Keywords
This publication has 34 references indexed in Scilit:
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- Making malaria treatment policy in the face of drug resistancePathogens and Global Health, 1999
- Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan AfricaTropical Medicine & International Health, 1998
- Chloroquine or amodiaquine with sulfadoxine-pyrimethamine treatment for uncomplicated malaria a systematic review combined as aPathogens and Global Health, 1998
- Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in ZaireTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Malaria: Living with drug resistanceParasitology Today, 1993
- Beyond Chloroquine: Implications of Drug Resistance for Evaluating Malaria Therapy Efficacy and Treatment Policy in AfricaThe Journal of Infectious Diseases, 1993
- How Frequent are Notified Severe Cutaneous Adverse Reactions to Fansidar®?Drug Safety, 1993
- Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness AnalysisInternational Journal of Epidemiology, 1992